AFP on MSN

AI helps doctors spot breast cancer in scans: world-first trial

Artificial intelligence helps doctors spot more cases of breast cancer when reading routine scans, a world-first trial found ...
Agence France-Presse

Agendia Announces NCCN Guideline Update Recognizing MammaPrint to Guide Personalized Anthracycline Use in HR+/HER2- Early‑Stage Breast Cancer

I am delighted that oncologists finally have a way to identify HR+/HER2- early breast cancer patients who will benefit from anthracycline therapy," said Joyce A. O’Shaughnessy, M.D., principal ...
Agence France-Presse

ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU ® (trastuzumab deruxtecan) in combination with pertuzumab for the first-line ...
WFMZ-TV

French scientists probe mRNA's potential to fight cancer | Afp | wfmz.com

A scientist in the French city of Orleans holds up a test tube containing messenger RNA While mRNA was discovered in the early 1960s, it rose to global prominence when it was used in some Covid ...
WFMZ-TV

'Forgotten' women demand justice in Spain breast cancer scandal

Juana Fernandez shows her scar from breast cancer surgery at the Amama office in Seville Oncology patients Charo Castro (L), Anabel Cano (2L) and Amparo Perez (R) pose with Amama breast cancer ...